[Low-green environment for the overcoming of granulocytopenic stages in leukemia therapy].
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D006801:Humans; D017053:Infection Control; D007938:Leukemia / Q000188:drug therapy*; D008722:Methods; D010357:Patient Isolators
D000900:Anti-Bacterial Agents; D001215:Asparaginase
Keimarmes Milieu zur Uberwindung granulocytopenischer Phasen in der Leukämietherapie.